Buy Altimmune Stock | ALT Stock Price & Latest News | Public
ALT

Altimmune

$0.00 (0.00%)Today
    Small Market Cap

    About ALT

    Altimmune, Inc. is a clinical stage immunotherapeutic biotechnology company. It focuses on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company's portfolio includes RespirVec...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.31
    -0.63
    -0.94
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.76

    Actual EPS
    Q3 2020

    Stats

    Market Cap$395,92M
    Volume47,47k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$35.10
    1 Year Low$1.51
    Open$12.97
    High$13.85
    Low$12.53

    Buy any stock with any amount of money.

    Download the App
    Download the app